Propanc Biopharma, Galaxy Payroll Group, and Arcadia Biosciences are the three Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are shares of very small companies that trade at a low price, often under a few dollars per share. They are generally considered highly speculative and risky for stock market investors because they can be thinly traded, more volatile, and harder to value than larger, more established stocks. These companies had the highest dollar trading volume of any Penny stocks within the last several days.
Propanc Biopharma (PPCB)
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.
Galaxy Payroll Group (GLXG)
Galaxy Payroll Group Limited, through its subsidiaries, provides payroll outsourcing, employment, and consultancy and market research services. It has operations in Hong Kong, Macau, the People’s Republic of China, Taiwan, Japan, Australia, Thailand, Malaysia, Vietnam, India, Indonesia, and the Philippines.
Read Our Latest Research Report on GLXG
Arcadia Biosciences (RKDA)
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Read Our Latest Research Report on RKDA
Read More
- MarketBeat’s Top Five Stocks to Own in June 2026
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
- Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
